Working... Menu
Trial record 2 of 57 for:    "Central serous chorioretinopathy"

Methotrexate for Central Serous Chorioretinopathy Treatment Trial (MTX4CSC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01633983
Recruitment Status : Unknown
Verified July 2012 by Edward Averbukh, Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : July 6, 2012
Last Update Posted : July 20, 2012
Information provided by (Responsible Party):
Edward Averbukh, Hadassah Medical Organization

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : July 2014
  Estimated Study Completion Date : July 2015